Literature DB >> 13677425

Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients.

Charles Rotimi1, Harold Daniel, Jie Zhou, Augustine Obisesan, Guanjie Chen, Yuanxiu Chen, Albert Amoah, Victoria Opoku, Joseph Acheampong, Kofi Agyenim-Boateng, Benjamin Ackon Eghan, Johnnie Oli, Godfrey Okafor, Ester Ofoegbu, Babatunde Osotimehin, Fayeofori Abbiyesuku, Thomas Johnson, Olufemi Fasanmade, Ayo Doumatey, Temilolu Aje, Francis Collins, Georgia Dunston.   

Abstract

OBJECTIVE: To quantify the prevalence of, and risk factors for, diabetic retinopathy and cataracts in patients with type 2 diabetes, and their spouse controls, enrolled from 5 centers in 2 West African countries (Ghana and Nigeria).
METHOD: The analysis cohort was made up of 840 subjects with type 2 diabetes, and their 191 unaffected spouse controls, who were enrolled and examined in Lagos, Enugu, and Ibadan, in Nigeria, and in Accra and Kumasi, in Ghana. A diagnosis of diabetic retinopathy was made only where a participant had a minimum of one microaneurysm in any field, as well as exhibiting hemorrhages (dot, blot, or flame shaped), and maculopathy (with or without clinically significant edema).
RESULTS: Average duration of diabetes was 7.0 years, and mean age at diagnosis was 46.5 years. Prevalence of diabetic retinopathy was 17.9%. Cataracts were present in 44.9% of the patients with type 2 diabetes, and in 18.3% of spouse controls. The risk of developing retinopathy increased more than 3-fold for patients at the highest fasting plasma glucose (FPG) level (OR=3.4; 95% CI, 1.8-6.3), compared to patients at the lowest FPG level. The odds ratios for persons with diabetes for 10 years or more, compared to persons with diabetes for less than 5 years, was 7.3 (95% CI, 4.3-12.3) for retinopathy, and 2.6 (95% CI, 1.5-4.5) for cataracts.
CONCLUSIONS: Cataracts were a more important cause of vision impairment than was diabetic retinopathy in this cohort. The prevalence of cataracts in patients with diabetes was more than twice that of their spouse controls, indicating that type 2 diabetes is an important risk factor for cataract formation. Individuals who developed type 2 diabetes at an earlier age were more likely to develop both diabetic retinopathy and cataracts. A strong positive association was observed between FPG level, duration of diabetes, and risk of retinopathy and cataracts. The low prevalence of retinopathy and cataracts observed within the first 5 years of diagnosis of diabetes in this cohort, suggests that intensive blood glucose control may reduce the risk of the development and progression of retinopathy and cataracts. In this regard, early eye examination, preferably at first presentation of elevated blood glucose, is highly recommended.

Entities:  

Mesh:

Year:  2003        PMID: 13677425

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  28 in total

Review 1.  The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis.

Authors:  Masoud Mohammadi; Ali Akbar Vaisi Raiegani; Rostam Jalali; Akram Ghobadi; Nader Salari
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

2.  Relationship between corneal sensitivity and diabetic retinopathy among diabetics attending a Nigerian Teaching Hospital.

Authors:  Monsurah Olabimpe Salami; Olufisayo Temitayo Aribaba; Kareem Olatunbosun Musa; Adekunle Rotimi-Samuel; Adeola Olukorede Onakoya
Journal:  Int Ophthalmol       Date:  2020-06-06       Impact factor: 2.031

3.  Oxidative stress-elevated high gamma glutamyl transferase levels, and aging, intake of tropical food plants, migration and visual disability in Central Africans.

Authors:  Benjamin Longo-Mbenza; Moïse Mvitu Muaka; Etienne Mokondjimobe; Dalida Kibokela Ndembe; Doris Tulomba Mona; Baudouin Buassabu-Bu-Tsumbu
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

4.  Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study.

Authors:  Adam D Lewis; Ruth E Hogg; Manju Chandran; Lillian Musonda; Lorraine North; Usha Chakravarthy; Sobha Sivaprasad; Geeta Menon
Journal:  Eye (Lond)       Date:  2018-03-05       Impact factor: 3.775

5.  Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.

Authors:  Bashira A Charles; Yvette P Conley; Guanjie Chen; Rachel G Miller; Janice S Dorman; Michael B Gorin; Robert E Ferrell; Susan M Sereika; Charles N Rotimi; Trevor J Orchard
Journal:  Ophthalmic Res       Date:  2010-11-19       Impact factor: 2.892

6.  Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.

Authors:  Xiaodan Zhang; Jiangpei Zhao; Tongfeng Zhao; Huanliang Liu
Journal:  Endocrine       Date:  2014-10-30       Impact factor: 3.633

7.  Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.

Authors:  Michael Olamoyegun; Waheed Ibraheem; Sandra Iwuala; Morenike Audu; Babatope Kolawole
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

8.  Retinopathy among type 2 diabetic patients seen at a tertiary hospital in Nigeria: a preliminary report.

Authors:  Adeyinka Ashaye; Ayodeji Arije; Modupe Kuti; Bolutife Olusanya; Ezekiel Ayeni; Adesoji Fasanmade; Kehinde Akinlade; Millicent Obajimi; Jokotade Adeleye
Journal:  Clin Ophthalmol       Date:  2008-03

9.  Case-control studies and risk factors for cataract in two population studies in Nigeria.

Authors:  S I Echebiri; P G C Odeigah; S N Myers
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10

Review 10.  A sub-Saharan African perspective of diabetes.

Authors:  G V Gill; J-C Mbanya; K L Ramaiya; S Tesfaye
Journal:  Diabetologia       Date:  2008-10-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.